Survival in Patients with Cystic Fibrosis.

Authors

  • Giselle Lucila Vázquez Gutiérrez Universidad de Ciencias Médicas de Granma.Cuba.
  • Pedro Alberto Sariol González Hospital Clínico Quirúrgico Celia Sánchez Manduley. Granma, Cuba.
  • Jimmy Javier Calás Torres Universidad de Ciencias Médicas de Granma.Cuba.
  • Jesús Daniel de la Rosa Santana Policlínico Docente Rene Vallejo Ortiz.Granma.Cuba.
  • Luis Armando Martínez Marreiro Universidad de Ciencias Médicas de Granma.Cuba.
  • Julio Roberto Vázquez Palanco Hospital Pediátrico Docente Hermanos Cordové.Granma.Cuba.

Keywords:

cystic fibrosis, genetic diseases, survival analysis, survival, mean survival time, mutation.

Abstract

Introduction: Cystic fibrosis is no longer a pediatric disease but a chronic adult disease. There are multiple factors that condition the survival of these patients.

Objective: To characterize and determine the survival of pediatric patients with cystic fibrosis hospitalized in a specialized center.

Methods: Retrospective cohort study whose universe consisted of 27 patients included in the Granma provincial cystic fibrosis registry, 2003-2018. Variables were analyzed: current age and gender, genetic variant, presence of germs, clinical forms and survival after diagnosis and treatment. The Kaplan-Meier method and Log-Rank Test were used, for a significance level of 95 %.

Results: 40.7% of patients was currently over 15 years of age, male sex predominated (63 %) and the F508del mutation in its heterozygous genetic variant (44.4 %). The average survival was 21.4 years, there were no significant differences according to gender, clinical forms and types of germs.

Conclusions: The average survival rate of patients with cystic fibrosis in Granma, Cuba, was 21.4 years, lower than that documented in developed countries. The Cuban State guarantees resources for the care of these patients, despite the country's economic difficulties.

 

Downloads

Download data is not yet available.

Author Biographies

Giselle Lucila Vázquez Gutiérrez, Universidad de Ciencias Médicas de Granma.Cuba.

1Especialista de II Grado en Pediatría. Profesor Asistente. Investigadora Agregada.

Pedro Alberto Sariol González, Hospital Clínico Quirúrgico Celia Sánchez Manduley. Granma, Cuba.

Rspecialista d Primer Grado e Cardiología.

Jimmy Javier Calás Torres, Universidad de Ciencias Médicas de Granma.Cuba.

Estudiante de Segundo Año de la carrera de Medicina. Alumno Ayudante de Inmunología.

Jesús Daniel de la Rosa Santana, Policlínico Docente Rene Vallejo Ortiz.Granma.Cuba.

Residente de Primer año en Medicina General Integra.

Luis Armando Martínez Marreiro, Universidad de Ciencias Médicas de Granma.Cuba.

Especialista en Segundo Grado en Bioestadística.  Investigador Auxiliar yProfeor Auxiliar

Julio Roberto Vázquez Palanco, Hospital Pediátrico Docente Hermanos Cordové.Granma.Cuba.

Especialista de II Grado en Pediatría y Medicina Intensiva-Emergencias. Profesor Auxiliar.

Published

2023-04-06

How to Cite

1.
Vázquez Gutiérrez GL, Sariol González PA, Calás Torres JJ, de la Rosa Santana JD, Martínez Marreiro LA, Vázquez Palanco JR. Survival in Patients with Cystic Fibrosis. Rev Cubana Pediatría [Internet]. 2023 Apr. 6 [cited 2025 Jul. 2];95. Available from: https://revpediatria.sld.cu/index.php/ped/article/view/3962

Issue

Section

PEDIATRÍA